Cyber harassment of female scientists will not be the new norm.
作者信息
Samer Caroline, Lacombe Karine, Calmy Alexandra
机构信息
Pharmacogenomics and Personalized Therapy Unit, Clinical Pharmacology and Toxicology Division, Geneva University Hospitals, Switzerland; Faculty of Medicine, University of Geneva, Switzerland.
Infectious Diseases Department, Saint-Antoine Hospital, APHP, Paris, France; Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France; Faculty of Medicine, Sorbonne Université, Paris, France.
出版信息
Lancet Infect Dis. 2021 Apr;21(4):457-458. doi: 10.1016/S1473-3099(20)30944-0. Epub 2020 Dec 24.
Abstract
摘要
相似文献
1
Cyber harassment of female scientists will not be the new norm.对女科学家的网络骚扰不会成为新常态。
Lancet Infect Dis. 2021 Apr;21(4):457-458. doi: 10.1016/S1473-3099(20)30944-0. Epub 2020 Dec 24.
2
Subjective health complaints and exposure to peer victimization among disabled and non-disabled adolescents: A population-based study in Sweden.残疾与非残疾青少年的主观健康抱怨及遭受同伴欺凌情况：瑞典一项基于人群的研究
Scand J Public Health. 2018 Mar;46(2):262-271. doi: 10.1177/1403494817705558. Epub 2017 Jul 11.
3
Chloroquine as Chemoprophylaxis for COVID-19: Will This Work.氯喹用作COVID-19的化学预防：这会有效吗？
Infect Disord Drug Targets. 2021;21(4):473-474. doi: 10.2174/1871526520666200726224802.
4
The Rise and Fall of Hydroxychloroquine and Chloroquine in COVID-19.羟氯喹和氯喹在 COVID-19 中的兴衰。
J Pharm Pract. 2022 Dec;35(6):971-978. doi: 10.1177/0897190021997399. Epub 2021 Apr 28.
5
Ototoxicity prevention during the SARS-CoV-2 (COVID-19) emergency.在 SARS-CoV-2（COVID-19）紧急情况下预防耳毒性。
J Glob Antimicrob Resist. 2020 Dec;23:263-264. doi: 10.1016/j.jgar.2020.09.030. Epub 2020 Oct 17.
6
G6PD and chloroquine: Selecting the treatment against SARS-CoV-2?葡萄糖-6-磷酸脱氢酶与氯喹：针对新型冠状病毒肺炎选择治疗方法？
J Cell Mol Med. 2020 May;24(9):4913-4914. doi: 10.1111/jcmm.15312. Epub 2020 Apr 16.
7
Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2.氯喹不能抑制 SARS-CoV-2 感染人肺细胞。
Nature. 2020 Sep;585(7826):588-590. doi: 10.1038/s41586-020-2575-3. Epub 2020 Jul 22.
8
Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.突破：磷酸氯喹在临床研究中显示出对 COVID-19 相关肺炎的明显疗效。
Biosci Trends. 2020 Mar 16;14(1):72-73. doi: 10.5582/bst.2020.01047. Epub 2020 Feb 19.
9
Toxicity of chloroquine and hydroxychloroquine following therapeutic use or overdose.氯喹和羟氯喹在治疗性使用或过量使用后的毒性。
Clin Toxicol (Phila). 2021 Jan;59(1):12-23. doi: 10.1080/15563650.2020.1817479. Epub 2020 Sep 22.
10
Efficacy and safety of hydroxychloroquine/chloroquine against SARS-CoV-2 infection: A systematic review and meta-analysis - Authors reply.羟氯喹啉/氯喹啉治疗新型冠状病毒肺炎的疗效与安全性：一项系统评价与荟萃分析——作者回复
J Infect Chemother. 2021 Oct;27(10):1539-1540. doi: 10.1016/j.jiac.2021.07.010. Epub 2021 Jul 16.
引用本文的文献
1
Race and gender biases persist in public perceptions of scientists' credibility.在公众对科学家可信度的认知中，种族和性别偏见依然存在。
Sci Rep. 2025 Mar 31;15(1):11021. doi: 10.1038/s41598-025-87321-z.
2
"The chilling effect": Medical scientists' responses to audience feedback on their media appearances during the COVID-19 pandemic.“寒蝉效应”：医学科学家对 COVID-19 大流行期间其媒体露面的观众反馈的回应。
Public Underst Sci. 2023 Jul;32(5):546-560. doi: 10.1177/09636625221146749. Epub 2023 Jan 12.
本文引用的文献
1
Hydroxychloroquine and COVID-19: a tale of populism and obscurantism.羟氯喹与2019冠状病毒病：一个民粹主义与蒙昧主义的故事。
Lancet Infect Dis. 2021 May;21(5):e121. doi: 10.1016/S1473-3099(20)30866-5. Epub 2020 Nov 13.
2
COVID-19 medical papers have fewer women first authors than expected.COVID-19 医学论文中女性第一作者的数量低于预期。
Elife. 2020 Jun 15;9:e58807. doi: 10.7554/eLife.58807.
3
Where are the women? Gender inequalities in COVID-19 research authorship.女性都在哪里？新冠疫情研究作者身份中的性别不平等现象。
BMJ Glob Health. 2020 Jul;5(7). doi: 10.1136/bmjgh-2020-002922.
4
Death threats after a trial on chloroquine for COVID-19.一项关于氯喹治疗新冠肺炎的试验后出现死亡威胁。
Lancet Infect Dis. 2020 Jun;20(6):661. doi: 10.1016/S1473-3099(20)30383-2.
5
Harassment in science is real.科学界的骚扰现象确实存在。
Science. 2017 Dec 8;358(6368):1223. doi: 10.1126/science.aar6134.
Zotero 插件